Uterin Fibroid Embolizasyon İşleminde Kullanılan Mikroküre Boyutunun Tedaviye Etkilerinin Retrospektif Analizi

Giriş: Uterin fibroidlerin tedavisinde altın standart yöntem minimal invaziv uterus koruyucu cerrahilerdir. Uterin fibroid embolizasyonu işlemi yaklaşık 20 yıldır uygulanmaktadır. Embolizan ajan olarak kullanılan mikroküre boyutlarının UFE tedavisine etkileri retrospektif olarak araştırılmıştır. Gereç ve Yöntemler: Retrospektif çalışmamızda UFE uygulanan 44 hastadan 500 Mikron ve altı boyutta mikroküreler ile tedaviye başlayan hastalar (Grup 1) ile 700 Mikron ve üstü mikroküre kullanılan hastaların (Grup 2) sonuçları karşılaştırıldı. Ağrı skorlaması, semptomlar ve dominant fibroid volümü işlem öncesi ve UFE sonrası 6. ay sonuçları karşılaştırıldı. Bulgular:Çok ciddi ağrı ve ciddi ağrı skorlayan hastaların sayısı Grup 1’de daha fazladır. Grup 1 ortalama ağrı skoru 4,9 iken Grup 2’de bu skor 3,6 bulundu(P

Anahtar Kelimeler:

Leiomyoma, uterine artery embolization, microspheres

Retrsopective analysis of microsphere’s size and effects on uterin fibroid embolization treatments

İntroduction: The gold standard method in the treatment of uterine fibroids is minimally invasive uterus-sparing surgery. Uterine fibroid embolization procedure has been practiced for about 20 years. The effects of microsphere sizes used as embolizing agents on UFE treatment were investigated in our retropective study. Materials and Methods: In our retrospective study, the results of 44 patients who underwent UFE investigated. We formed to 2 groups; Group 1 started to treatment with initial microspheres of 500 micron or less size and Group 2 patients who used microspheres of 700 micron and above as initial vial. The results of pain scoring, symptoms and dominant fibroid volume before the procedure and at 6 months after UFE were compared. Results: The number of patients scored very severe pain and severe pain was higher in Group 1. While the mean pain score in Group 1 was 4.9, it was 3.6 in Group 2 (P

Keywords:

Leiomyoma, uterine artery embolization, microspheres,

PDF

___

1) Sohn GS, Cho S, Kim YM, Cho CH, Kim MR, Lee SR, Working Group of Society of Uterine Leiomyoma. Current medical treatment of uterine fbroids. Obstet Gynecol Sci. 2018;61(2):192–201.
2)E. Downes, V. Sikirica, J. Gilabert-Estelles et al., “The burden of uterine fibroids in five European countries,” European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 152, no.1, pp. 96–102, 2010.
3)S. Okolo, “Incidence, aetiology and epidemiology of uterine fibroids,” Best Practice & Research: Clinical Obstetrics & Gynaecology, vol. 22, no. 4, pp. 571–588, 2008.
4)El-Balat A, DeWilde RL, Schmeil I, Tahmasbi-Rad M, Bogdanyova S, Fathi A, Becker S, Modern Myoma Treatment in the Last 20 Years: A Review of the Literature Biomed Res Int 2018 Jan 24;2018:4593875.
5)Spies J, Allison S, Sterbis K, et al. Polyvinyl alcohol particles and trisacryl gelatin microspheres for uterine artery embolization for leiomyomas: results of a randomized comparative study. J Vasc Interv Radiol. 2004; 15:793–800.
6)Jiang W, Shen Z, Luo H, Hu X, Zhu X, Comparison of polyvinyl alcohol and tris-acryl gelatin microsphere materials in embolization for symptomatic leiomyomas: a systematic review. Minim Invasive Ther Allied Technol. 2016 Dec;25(6):289-300.
7)Duvnjak S, Ravn P, Green A, Andersen PE, Uterine fibroid embolization with acrylamido polyvinyl microspheres: prospective 12-month clinical and MRI follow-up study, Acta Radiol. 2017 Aug;58(8):952-958.
8)Olive DL, Lindheim SR, Pritts EA, Non-surgical management of leiomyoma: impact on fertility Curr Opin Obstet Gynecol. 2004 Jun;16(3):239-43.
9)Siskin GP, Englander M, Stainken BF, Ahn J, Dowling K, Dolen EG. Embolic agents used for uterine leiomyoma embolization. AJR Am J Roentgenol 2000; 175:767–773.
10)Yu SCH, Lok I, Ho SSY, Tong MMB, Hui JWY. Comparison of Clinical Outcomes of Tris-acryl Microspheres Versus Polyvinyl Alcohol Microspheres for Uterine Artery Embolization for Leiomyomas: Results of a Randomized Trial. J Vasc Interv Radiol 2011; 22:1229-1235.
11)Chua GC, Wilsher M, Young MP, Manyonda I, Morgan R, Belli AM. Comparison of particle penetration with non-spherical polyvinyl alcohol versus trisacryl gelatin microspheres in women undergoing pre-myomectomy uterine artery embolization. Clin Radiol 2005; 60:116–212.
12)Siskin GP, Beck A, Schuster M, Mandato K, Englander M, Herr DA. Leiomyoma Infarction after Uterine Artery Embolization: A Prospective Randomized Study Comparing Tris-acryl Gelatin Microspheres versus Polyvinyl Alcohol Microspheres. J Vasc Interv Radiol 2008; 19: 58-65.
13)Shlansky-Goldberg RD, Rosen MA, Mondschein JI, Stavropoulos SW, Trerotola SO, Diaz-Cartelle J, Comparison of Polyvinyl Alcohol Microspheres and Tris-Acryl Gelatin Microspheres for Uterine Fibroid Embolization: Results of a Single-Center Randomized Study. J Vasc Interv Radiol 2014; 25:823–832.
14)Liaw JVP, Yun C-H, Walker TG, Kalva SP, Janne d'Othée B, Comparison of clinical and MR imaging outcomes after uterine fibroid embolization with Bead Block and Embosphere Eur J Radiol. 2012 Jun;81(6):1371-1375.
15)Bilhim T, Pisco JM, Duarte M, Oliveira AG, Polyvinyl Alcohol Particle Size for Uterine Artery Embolization: A Prospective Randomized Study of Initial Use of 350 –500M Particles versus Initial Use of 500 –700 M Particles J Vasc Interv Radiol 2011; 22:21–27.